News

Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control tumors in preclinical models... Read more

An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy... Read more

A technique that enables scientists to record gene mutations and patterns of gene activity in individual cells has been extended to cover RNA splicing as well, in a study led by researchers at Weill Cornell Medicine, the New... Read more

Weill Cornell Medicine and Columbia University have been awarded a $9.8 million, five-year grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to help combat cancer disparities fueled... Read more

Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions, according to a study from... Read more

Weill Cornell Medicine has received a grant from the National Institutes of Health (NIH) as part of a new $140 million Common Fund program to study somatic mosaicism, a phenomenon in which organs and tissues develop... Read more

Dr. James C. Lo , an associate professor of medicine and Dr. Lisa G. Roth , an associate professor of pediatrics, both from Weill Cornell Medicine, were elected members of the American Society for Clinical Investigation (... Read more